Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentino Conter

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Haematologica|April 13, 2004
Outcome of very late relapse in children with acute lymphoblastic leukemiaCarmelo Rizzari, Maria Grazia Valsecchi, Maurizio Aricò, et al.
British Journal of Haematology|December 21, 2021
Precursor B-cell acute lymphoblastic leukaemia-a global viewAndrea Biondi, Valentino Conter, Mammen Chandy, et al.
Cancer|December 12, 2022
How should childhood acute lymphoblastic leukemia relapses in low-income and middle-income countries be managed: The AHOPCA-ALL study group experienceDarrell Espinoza, Jessica G Blanco Lopez, Roberto Vasquez, et al.
Frontiers in Oncology|July 25, 2022
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic LeukemiaGiulia Veltri, Federica Lovisa, Giuliana Cortese, et al.
Pediatric Blood & Cancer|December 31, 2013
Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative programCarlos Pacheco, Giovanna Lucchini, Maria Grazia Valsecchi, et al.
Lancet (London, England)|January 16, 2007
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trialValentino Conter, Maria Grazia Valsecchi, Daniela Silvestri, et al.
Blood|July 2, 2002
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol IIMaurizio Aricò, Maria Grazia Valsecchi, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrowGiuseppe Basso, Marinella Veltroni, Maria Grazia Valsecchi, et al.
Pediatric Blood & Cancer|December 19, 2018
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, et al.
Oncotarget|July 16, 2014
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcomeGloria Milani, Paola Rebora, Benedetta Accordi, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Haematologica|April 13, 2004
Outcome of very late relapse in children with acute lymphoblastic leukemiaCarmelo Rizzari, Maria Grazia Valsecchi, Maurizio Aricò, et al.
British Journal of Haematology|December 21, 2021
Precursor B-cell acute lymphoblastic leukaemia-a global viewAndrea Biondi, Valentino Conter, Mammen Chandy, et al.
Cancer|December 12, 2022
How should childhood acute lymphoblastic leukemia relapses in low-income and middle-income countries be managed: The AHOPCA-ALL study group experienceDarrell Espinoza, Jessica G Blanco Lopez, Roberto Vasquez, et al.
Frontiers in Oncology|July 25, 2022
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic LeukemiaGiulia Veltri, Federica Lovisa, Giuliana Cortese, et al.
Pediatric Blood & Cancer|December 31, 2013
Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative programCarlos Pacheco, Giovanna Lucchini, Maria Grazia Valsecchi, et al.
Lancet (London, England)|January 16, 2007
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trialValentino Conter, Maria Grazia Valsecchi, Daniela Silvestri, et al.
Blood|July 2, 2002
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol IIMaurizio Aricò, Maria Grazia Valsecchi, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrowGiuseppe Basso, Marinella Veltroni, Maria Grazia Valsecchi, et al.
Pediatric Blood & Cancer|December 19, 2018
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, et al.
Oncotarget|July 16, 2014
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcomeGloria Milani, Paola Rebora, Benedetta Accordi, et al.
Pageof 14